160 related articles for article (PubMed ID: 21041510)
1. Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility.
Chou S; Bowlin TL
Antimicrob Agents Chemother; 2011 Jan; 55(1):382-4. PubMed ID: 21041510
[TBL] [Abstract][Full Text] [Related]
2. Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure.
Chou S; Marousek G; Bowlin TL
Antimicrob Agents Chemother; 2012 Jan; 56(1):197-201. PubMed ID: 21968367
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus UL97 kinase catalytic domain mutations that confer multidrug resistance.
Chou S; Ercolani RJ; Marousek G; Bowlin TL
Antimicrob Agents Chemother; 2013 Jul; 57(7):3375-9. PubMed ID: 23650173
[TBL] [Abstract][Full Text] [Related]
4. Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase.
James SH; Hartline CB; Harden EA; Driebe EM; Schupp JM; Engelthaler DM; Keim PS; Bowlin TL; Kern ER; Prichard MN
Antimicrob Agents Chemother; 2011 Oct; 55(10):4682-91. PubMed ID: 21788463
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus mutants resistant to ganciclovir and cidofovir differ in susceptibilities to synguanol and its 6-ether and 6-thioether derivatives.
Chou S; Komazin-Meredith G; Williams JD; Bowlin TL
Antimicrob Agents Chemother; 2014; 58(3):1809-12. PubMed ID: 24379208
[TBL] [Abstract][Full Text] [Related]
6. Recombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistance.
Chou S
Antimicrob Agents Chemother; 2010 Jun; 54(6):2371-8. PubMed ID: 20385869
[TBL] [Abstract][Full Text] [Related]
7. Ganciclovir resistance mutations in UL97 and UL54 genes of Human cytomegalovirus isolates resistant to ganciclovir.
Foulongne V; Turrière C; Diafouka F; Abraham B; Lastere S; Segondy M
Acta Virol; 2004; 48(1):51-5. PubMed ID: 15230476
[TBL] [Abstract][Full Text] [Related]
8. Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene.
Chou S; Van Wechel LC; Lichy HM; Marousek GI
Antimicrob Agents Chemother; 2005 Jul; 49(7):2710-5. PubMed ID: 15980340
[TBL] [Abstract][Full Text] [Related]
9. Resistance of human cytomegalovirus to cyclopropavir maps to a base pair deletion in the open reading frame of UL97.
Gentry BG; Vollmer LE; Hall ED; Borysko KZ; Zemlicka J; Kamil JP; Drach JC
Antimicrob Agents Chemother; 2013 Sep; 57(9):4343-8. PubMed ID: 23817384
[TBL] [Abstract][Full Text] [Related]
10. Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study.
Campos AB; Ribeiro J; Pinho Vaz C; Campilho F; Branca R; Campos A; Baldaque I; Medeiros R; Boutolleau D; Sousa H
Antiviral Res; 2017 Feb; 138():86-92. PubMed ID: 27887982
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir.
Chou S; Waldemer RH; Senters AE; Michels KS; Kemble GW; Miner RC; Drew WL
J Infect Dis; 2002 Jan; 185(2):162-9. PubMed ID: 11807689
[TBL] [Abstract][Full Text] [Related]
12. Ganciclovir and maribavir cross-resistance revisited: Relative drug susceptibilities of canonical cytomegalovirus mutants.
Chou S; Watanabe J
Antiviral Res; 2024 Feb; 222():105792. PubMed ID: 38163624
[TBL] [Abstract][Full Text] [Related]
13. Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens.
Chou S; Marousek GI; Van Wechel LC; Li S; Weinberg A
Antimicrob Agents Chemother; 2007 Nov; 51(11):4160-2. PubMed ID: 17709468
[TBL] [Abstract][Full Text] [Related]
14. Z-isomers of 2-hydroxymethylcyclopropylidenemethyl adenine (synadenol) and guanine (synguanol) are active against ganciclovir- and foscarnet-resistant human cytomegalovirus UL97 mutants.
Baldanti F; Sarasini A; Drach JC; Zemlicka J; Gerna G
Antiviral Res; 2002 Dec; 56(3):273-8. PubMed ID: 12406510
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of Ganciclovir Resistance in Cytomegalovirus Isolates by Phenotypic and Genotypic Methods].
Sarınoğlu RC; Çolak D; Küpesiz OA; Kuşkucu MA; Yalçın K; Sağlık İ; Mutlu D; Midilli K; Peker BO; Özhak B; Özkul A; Foldes K
Mikrobiyol Bul; 2023 Jul; 57(3):401-418. PubMed ID: 37462304
[TBL] [Abstract][Full Text] [Related]
16. [Mutations in the
Demin MV; Tikhomirov DS; Biderman BV; Drokov MY; Sudarikov AB; Tupoleva TA; Filatov FP
Vopr Virusol; 2022 Mar; 67(1):37-47. PubMed ID: 35293187
[TBL] [Abstract][Full Text] [Related]
17. Multiple ganciclovir-resistant strains in a newborn with symptomatic congenital human cytomegalovirus infection.
Campanini G; Zavattoni M; Cristina E; Gazzolo D; Stronati M; Baldanti F
J Clin Virol; 2012 May; 54(1):86-8. PubMed ID: 22381918
[TBL] [Abstract][Full Text] [Related]
18. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus drug resistance mutations in transplant recipients with suspected resistance.
Recio V; González I; Tarragó D
Virol J; 2023 Jul; 20(1):153. PubMed ID: 37464399
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus UL97 kinase mutations that confer maribavir resistance.
Chou S; Wechel LC; Marousek GI
J Infect Dis; 2007 Jul; 196(1):91-4. PubMed ID: 17538888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
